Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

NCT02553928 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Dementia (AD)

Interventions

DRUG: Memantine (once daily)
DRUG: Memantine (twice daily)

Sponsor

H. Lundbeck A/S